ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Neutral

AI Analysis

Summary

ORIC Pharmaceuticals granted 44,400 non-qualified stock options and 7,200 restricted stock units to three new non-executive employees hired in June 2026, as disclosed under Nasdaq listing rules.

Importance:1/10

Sentiment:

0.00

employee compensationstock optionsRSUsinducement grantshiring

Related Companies

$ORIC

Read the original article

Published by GlobeNewswire Clinical Studies on July 2, 2026 8:30 PM

Read Original